Épidémiologie de l’HTA en dialyse
Néphrologie & Thérapeutique, ISSN: 1769-7255, Vol: 3, Issue: SUPPL. 3, Page: S143-S149
2007
- 1Citations
- 6Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations1
- Citation Indexes1
- CrossRef1
- Captures6
- Readers6
Article Description
Le contrôle insuffisant de l’hypertension artérielle chez les patients dialysés explique pour un part la fréquence élevée de la morbi-mortalité cardio-vasculaire en dialyse. Les enquêtes épidémiologiques réalisées au cours de la dernière décennie montrent que la prévalence de l’hypertension en dialyse demeure élevée, variant de 55 à 85 % selon l’âge moyen de la population étudiée et les périodes, malgré l’amélioration des stratégies de dialyse. Les patients traités par dialyse péritonéale ne sont pas mieux contrôlés que ceux traités par hémodialyse. Des médicaments antihypertenseurs sont administrés chez trois quarts des patients dialysés. Les stratégies de dialyse qui augmentent le nombre de séances par semaine ou allongent la durée des séances d’hémodialyse conventionnelle améliorent le contrôle du volume hydro-sodé et par voie de conséquence la pression artérielle. L’athérosclérose, cause ou conséquence de l’hypertension chez les patients dialysés, lesquels sont de plus en plus âgés, conduit à ajuster les stratégies de traitement afin d’éviter l’hypotension artérielle qui augmente également la morbi-mortalité cardio-vasculaire de ces patients (épidémiologie inverse). Increased cardio-vascular morbi-mortality in dialysed patients is particularly due to an insufficiency of blood pressure control. Previous epidemiological surveys show that prevalence of dialysis hypertension is high, from 55 to 85 % according to period and mean âge of the studied population, despite an improvement of dialysis strategies during the last decade. Control of hypertension is not better in peritoneal dialysis than in haemodialysis. Antihypertensive drugs are administered to 3/4 of dialysed patients. Dialysis strategies which increase the number of sessions per week or the duration of each session in conventional haemodialysis improve the volume control and consequently the blood pressure. Atherosclerosis, cause or consequence of hypertension in dialysed elderly patients, more and more old, lead to adapt treatment strategies in order to prevent hypotension, which is also, a major risk factor of mobi-mortality in dialysed patients (reverse epidemiology).
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1769725507806298; http://dx.doi.org/10.1016/s1769-7255(07)80629-8; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=43049159807&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/18340679; https://linkinghub.elsevier.com/retrieve/pii/S1769725507806298; http://linkinghub.elsevier.com/retrieve/pii/S1769725507806298; http://api.elsevier.com/content/article/PII:S1769725507806298?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S1769725507806298?httpAccept=text/plain; http://dx.doi.org/10.1016/s1769-7255%2807%2980629-8; https://dx.doi.org/10.1016/s1769-7255%2807%2980629-8
JLE
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know